Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hendrickx

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Acta Chirurgica Belgica|March 1, 1983
[Diverticular disease of the left colon. Belgian surgical experience. Multicenter study of 962 cases]P Mendes da Costa, J Ansay, A Beernaerts, et al.
Cell Reports. Medicine|June 25, 2025
Impact of the tumor immune contexture in microsatellite-stable metastatic colorectal cancer treated with avelumab, cetuximab, and irinotecanNicolas Huyghe, Elena Benidovskaya, Tariq Masoodi, et al.
Journal of Translational Medicine|February 21, 2024
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancerMike Mason, Óscar Lapuente-Santana, Anni S Halkola, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Acta Chirurgica Belgica|March 1, 1983
[Diverticular disease of the left colon. Belgian surgical experience. Multicenter study of 962 cases]P Mendes da Costa, J Ansay, A Beernaerts, et al.
Cell Reports. Medicine|June 25, 2025
Impact of the tumor immune contexture in microsatellite-stable metastatic colorectal cancer treated with avelumab, cetuximab, and irinotecanNicolas Huyghe, Elena Benidovskaya, Tariq Masoodi, et al.
Journal of Translational Medicine|February 21, 2024
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancerMike Mason, Óscar Lapuente-Santana, Anni S Halkola, et al.
Pageof 5